Nicotine Addiction: Prevalence And Treatment

A Seminar released on June 13, 2008 in The Lancet discusses nicotine addiction, and the potential for reducing its disease burden and death toll by improving public knowledge and using treatments individual to patients. This includes the potential creation of an antinicotine vaccine.

Nicotine is a stimulant classically found in tobacco, and its chronic addiction is primary cause of habitual smoking. According to the seminar, there are approximately 1.2 billion smokers and approximately half of them will die from diseases directly caused by smoking. Currently, about five million smokers die each year, and if present trends continue this could increase to ten million each year by 2025.

More of these smokers are men than women, necessitating separate studies by gender. For instance, of the world’s male population, 92% of them live in countries where more than 25% of all males smoke. In contrast, in the world’s female population, 10% live in countries where female smoking frequency is above 24%. In the United Kingdom and the United States, between 25-35% of all males smoke. In the female population, however, there is some discrepancy, as in the USA 14-24% of women smoke but more than 24% smoke in the UK.

The distribution of smokers varies by country, ranging from as little to 5% of the population to over 55%. Some countries where male smoking prevalence is above 55% include Russia and Kenya. The female smoking frequencies are above 24% in Brazil, Germany, Spain, and the UK.

Terminating an addiction to smoking is often recognized as a significant challenge. In the USA, over 70% of the smoking population want to quit every year and 45% attempt it. However, less than 5% of the general population is successful in this endeavor.

Even simple advice from a health care professional can help improve these rates. Following guidelines set forward recently in the US, the Seminar first examines the role of counseling in quitting smoking, addressing topics including problem solving, coping, and motivational skills.

According to the Seminar, this rate of termination can be enhanced by treatment for nicotine addiction itself. “Pharmacotherpaies for nicotine dependence can enhance quit rates by about
two-three fold,” state the authors. They discuss and evaluate a number of nicotine-replacement therapies (NRTs) such as patches or nicotine gum, non-nicotine products based on efficacy, side effects, and precautions for each. Additionally, they examine improved rates of success with combinations of the nicotine patch and other products such as nicotine gum.

The authors of the Seminar examine not just the characteristics of termination, but also the limited benefits of cigarette reduction, which is also achieved with higher frequency with the use of NRTs. They say, however, that these effects are counteracted by changes in the habits of the smokers: “Smokers engage in substantial compensatory smoking – deeper inhalation per cigarette – so that a reduction of cigarette consumption of 50% or more results only in a 30% decrease in biomarkers for toxicant exposure.” Cigarette reduction’s primary benefit, therefore, may be that it acts as an intermediate step towards quitting.

There are some new treatments in development. One example is a nicotine vaccine which prompts the body’s immune system to develop antibodies against the substance, and for which preliminary trials are in progress. Another is the drug rimonabant, which selectively blocks a specific cannabinoid receptor, for which large, randomized trials are being performed. Finally, pharmacogenetics, a field in which treatment is matched to the patient based on his genetic profile, is examined.

The authors conclude with comments about nicotine addiction: “Nicotine or tobacco addiction should be treated as a chronic disorder. Treatment can need persistent efforts to try to assist tobacco users in their attempts at quitting. Relapse should be seen as a probable event…Treatment can improve these outcomes…The most crucial component of care is the actual delivery of such treatments.”

Dr Kenneth Warner of School of Public Health, Ann Arbor, MI, USA, and Dr Judith Longstaff Mackay, Bloomberg Initiative to Reduce Tobacco Use, Hong Kong, China, contributed an accompanying Comment in which they state the importance of The Framework Convention on Tobacco Control (FCTC,) which has presently been ratified by 154 countries. They indicate that the medical community should make a higher priority of treatment of tobacco dependence, especially in every day practice, and that they should lobby governments, who may have conflicts of interest due to tobacco lobbies, to put this legislation into effect. “Here is something simple, achievable, and unequivocally good that would relieve the suffering of literally millions of human beings,” they say.
__________
source: Medical News Today

More Treatment & Detox Articles

Quit alcohol to lead a better life

Drinking alcohol has time and again proven to be hazardous for all. Several tragedies and unpleasant incidents can be credited to heavy drinking habits. Though it may seem difficult, the habit can be given up by following some simple and smart steps. Every Year, thousands die in alcohol-related tragedies – acute alcohol poisonings, car accidents,….

Clinical physician argues changes needed to cut into alcohol abuse

Fighting the estimated $5 billion impact of alcohol and drug abuse on society requires more than stricter criminal laws, a physician told a local group Friday. Dr. Richard Brown, Wisconsin Initiative to Promote Healthy Lifestyles clinical director, argued there are several ways to cut such costs in courts, social services and health care: Boost community….

Our gift to our children: alcoholism

Alcohol disinhibits the parts of the brain that control thoughts, feelings and behaviour; that’s why adults drink. Of course, most of us view this less technically in terms of “relaxing” and “enjoying ourselves”. And in most cases, that’s what it lets us do. Yet alcohol’s extraordinary ability to disinhibit other adult impulses is well documented…..

Major Report Finds Screening and Early Intervention Program Used in Diverse Health Care Settings Dramatically Reduces Illicit Drug Use among Patients

Report found a 67.7 percent reduction in illicit drug use over a six month period among people receiving these services The Screening, Brief Intervention, and Referral to Treatment (SBIRT) program can reduce illicit drug use among patients seeking medical care in a wide variety of health care settings such as hospitals, physician offices, and community….

Youth drinking a plague in North Dakota

It’s proven that drinking and driving, binge drinking and underage drinking cause death and serious injury. Despite the statistics, members of the Legislature turn their heads away from the problem and continue to reap the sales tax revenue, as bars refuse to participate in server training and overserve patrons. Adults actually admit they feel there’s….